GW, MFA and UHS Finalize Agreement to Transition Clinical Operations to Capital Medical Group The George Washington University (GW), Medical Faculty Associates, Inc. (MFA), and Universal Health Services, Inc. (UHS)…
Henry Schein Appoints William K. “Dan” Daniel as Independent Chairman Following Stanley Bergman’s Retirement Henry Schein,announced the appointment of William K. “Dan” Daniel as Independent Chairman of the Board, marking…
Fulgent Genetics Announces Full Abstract Publication of FID-007 Combination Therapy in Head and Neck Cancer at ASCO 2026 Fulgent Genetics, a technology-driven life sciences company with established laboratory services and…
Datroway® Receives U.S. FDA Approval as First TROP2-Directed Antibody Drug Conjugate for First-Line Treatment of Metastatic Triple-Negative Breast Cancer in Patients Not Eligible for PD-1/PD-L1 Inhibitor Therapy Daiichi Sankyo and…
FDA Approves Gilead’s Hepcludex, Marking a Breakthrough for Patients Living With Chronic Hepatitis Delta The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Hepcludex® (bulevirtide-gmod) 8.5 mg,…
Johnson & Johnson and Abu Dhabi Launch Global Surgical Intelligence Network to Advance AI-Powered Operating Rooms Johnson & Johnson has announced a landmark collaboration with the Department of Health –…
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Guardant Health a leading precision oncology company headquartered in Palo Alto, California, has announced the approval and issuance of a…
Cord for Life® Completes Historic Phase 1 Clinical Trial Exploring Cord Blood Stem Cell Therapy for Lower Back Pain Cord for Life®has announced the successful completion of Phase 1 enrollment…
Novanta Reports Strong First Quarter 2026 Results with Double-Digit Revenue Growth and Rising Bookings Novanta a trusted technology partner for medical and advanced technology equipment manufacturers, announced its financial results…
PACS Group to Announce First Quarter 2026 Financial Results on May 11 one of the largest post-acute healthcare providers in the United States, has announced plans to release its financial…
Veradigm Launches Real-Time Health Network Platform for Independent Practices Veradigm has introduced its new Veradigm Health Network Architecture™, a platform designed to help independent healthcare practices gain access to the…
Delcath Shares New Real-World Findings From European Investigators Delcath Systems an interventional oncology company dedicated to advancing treatments for primary and metastatic liver cancers, announced the presentation of new clinical…